Evidence map›Paper›PMID 25454945›Full record

ArticleMolecular cell2014

A divergent role of the SIRT1-TopBP1 axis in regulating metabolic checkpoint and DNA damage checkpoint.

Tongzheng Liu, Yi-Hui Lin, Wenchuan Leng, Sung Yun Jung, Haoxing Zhang, Min Deng, Debra Evans, Yunhui Li, Kuntian Luo, Bo Qin and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Tongzheng LiuResearch Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Yi-Hui LinDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Wenchuan LengDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Sung Yun JungDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Haoxing ZhangDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Min DengDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Debra EvansDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Yunhui LiResearch Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Kuntian LuoResearch Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Bo QinDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Jun QinDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Jian YuanResearch Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, Shanghai 200120, China. Electronic address: yuanjian229@hotmail.com.
Zhenkun LouDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: lou.zhenkun@mayo.edu.
Mayo Clinic in Arizona · USTongji University · CNBaylor College of Medicine · USMayo Clinic · US

Funding

Targeted MV-CEA as a Potent Antitumor Agent against GBMP50CA108961 · NCI · MAYO CLINIC ROCHESTER · PI O'NEILL, BRIAN PATRICK · 2004 to 2015
$22.5M
Ubiquitination and the DNA Damage Response PathwayR01CA130996 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2008 to 2018
$3.3M
The Role of WSB1 in TumorigenesisR01CA189666 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2014 to 2018
$1.6M
Regultion of p53 DeubiquitinationR01CA148940 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2011 to 2015
$1.6M
Regulation of SirT1 by Deleted in Breast Cancer 1 (DBC1)R01CA129344 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2009 to 2013
$1.5M
NCI NIH HHS CA108961NCI NIH HHS CA129344NCI NIH HHS CA130996NCI NIH HHS CA148940NCI NIH HHS CA189666NCI NIH HHS P50 CA108961NCI NIH HHS R01 CA129344NCI NIH HHS R01 CA130996NCI NIH HHS R01 CA148940NCI NIH HHS R01 CA189666
6 · The paper itself

Abstract

DNA replication is executed only when cells have sufficient metabolic resources and undamaged DNA. Nutrient limitation and DNA damage cause a metabolic checkpoint and DNA damage checkpoint, respectively. Although SIRT1 activity is regulated by metabolic stress and DNA damage, its function in these stress-mediated checkpoints remains elusive. Here we report that the SIRT1-TopBP1 axis functions as a switch for both checkpoints. With glucose deprivation, SIRT1 is activated and deacetylates TopBP1, resulting in TopBP1-Treslin disassociation and DNA replication inhibition. Conversely, SIRT1 activity is inhibited under genotoxic stress, resulting in increased TopBP1 acetylation that is important for the TopBP1-Rad9 interaction and activation of the ATR-Chk1 pathway. Mechanistically, we showed that acetylation of TopBP1 changes the conformation of TopBP1, thereby facilitating its interaction with distinct partners in DNA replication and checkpoint activation. Taken together, our studies identify the SIRT1-TopBP1 axis as a key signaling mode in the regulation of the metabolic checkpoint and the DNA damage checkpoint.

Indexed as

DNA DamageStress, PhysiologicalAcetylationAnimalsCarrier ProteinsCell Cycle CheckpointsCell Cycle ProteinsCell LineDNA RepairDNA ReplicationHEK293 CellsHumansMiceProtein ConformationSignal TransductionSirtuin 1Carrier ProteinsCell Cycle Proteinsrad9 proteinSirtuin 1

Identifiers

PMID25454945
PMCPMC4386886
OpenAlexW2156387684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.